Globe Life Inc. (NYSE:GL) Shares Acquired by Mirae Asset Global Investments Co. Ltd.

Mirae Asset Global Investments Co. Ltd. boosted its position in Globe Life Inc. (NYSE:GL) by 39.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,988 shares of the company’s stock after purchasing an additional 2,547 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Globe Life were worth $984,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of GL. State Street Corp raised its stake in shares of Globe Life by 3.4% during the 3rd quarter. State Street Corp now owns 3,545,272 shares of the company’s stock worth $375,480,000 after buying an additional 115,432 shares during the last quarter. Principal Financial Group Inc. raised its position in Globe Life by 9.0% during the third quarter. Principal Financial Group Inc. now owns 105,315 shares of the company’s stock worth $11,154,000 after acquiring an additional 8,663 shares during the last quarter. Merit Financial Group LLC purchased a new stake in shares of Globe Life in the fourth quarter valued at about $487,000. Wealth Enhancement Advisory Services LLC grew its position in shares of Globe Life by 85.9% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 19,779 shares of the company’s stock valued at $2,095,000 after purchasing an additional 9,141 shares during the last quarter. Finally, Pacer Advisors Inc. grew its position in shares of Globe Life by 56.0% in the fourth quarter. Pacer Advisors Inc. now owns 10,199 shares of the company’s stock valued at $1,137,000 after purchasing an additional 3,662 shares during the last quarter. 81.61% of the stock is currently owned by hedge funds and other institutional investors.

Globe Life Stock Down 0.8 %

Shares of NYSE GL opened at $121.31 on Wednesday. The stock has a market capitalization of $10.18 billion, a PE ratio of 10.15 and a beta of 0.81. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50. The firm has a fifty day moving average of $113.67 and a 200-day moving average of $107.57. Globe Life Inc. has a 52-week low of $38.95 and a 52-week high of $132.00.

Globe Life (NYSE:GL) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. On average, analysts anticipate that Globe Life Inc. will post 13.57 EPS for the current year.

Globe Life Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Monday, January 6th were issued a $0.24 dividend. The ex-dividend date of this dividend was Monday, January 6th. This represents a $0.96 annualized dividend and a yield of 0.79%. Globe Life’s payout ratio is 8.03%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Raymond James upped their target price on Globe Life from $160.00 to $188.00 and gave the company a “strong-buy” rating in a research note on Tuesday, October 15th. Keefe, Bruyette & Woods upped their price objective on Globe Life from $135.00 to $137.00 and gave the company an “outperform” rating in a research report on Friday, January 10th. Jefferies Financial Group lifted their price objective on Globe Life from $107.00 to $114.00 and gave the stock a “hold” rating in a research report on Tuesday, December 10th. Morgan Stanley upped their target price on shares of Globe Life from $123.00 to $125.00 and gave the company an “equal weight” rating in a report on Tuesday. Finally, BMO Capital Markets started coverage on shares of Globe Life in a report on Thursday, January 23rd. They set a “market perform” rating and a $114.00 price target for the company. Five research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Globe Life presently has a consensus rating of “Moderate Buy” and an average price target of $132.30.

Insider Buying and Selling at Globe Life

In other news, Director Mark A. Blinn sold 3,000 shares of Globe Life stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $113.23, for a total transaction of $339,690.00. Following the sale, the director now owns 5,122 shares in the company, valued at $579,964.06. This trade represents a 36.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Frank M. Svoboda sold 14,340 shares of the company’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $108.80, for a total transaction of $1,560,192.00. Following the completion of the transaction, the chief executive officer now owns 16,396 shares of the company’s stock, valued at $1,783,884.80. This trade represents a 46.66 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 39,788 shares of company stock valued at $4,429,779 over the last ninety days. Corporate insiders own 1.51% of the company’s stock.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.